Online inquiry

IVTScrip™ mRNA-Human ATP1A1-AS1, (Cap 0, Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK21883MR)

This product GTTS-WK21883MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & Pseudo-UTP. It ecodes the ATP1A1-AS1 protein. This product can be used in FGFR1HighNME5- epithelial cell-related researches.
Specifications
Product type mRNA
Modified bases Pseudo-UTP
5' Cap Cap 0
Species Human
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 84852
UniProt ID Q5TC04
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ATP1A1-AS1, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK21883MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK25176MR IVTScrip™ mRNA-Human ATP11A-AS1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ATP11A-AS1
GTTS-WK16791MR IVTScrip™ mRNA-Human AP4B1-AS1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AP4B1-AS1
GTTS-WK27666MR IVTScrip™ mRNA-Human ARF4-AS1, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARF4-AS1
GTTS-WK25803MR IVTScrip™ mRNA-Human APCDD1L-AS1, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA APCDD1L-AS1
GTTS-WK23466MR IVTScrip™ mRNA-Human ARF4-AS1, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ARF4-AS1
GTTS-WK15945MR IVTScrip™ mRNA-Human AK124399, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AK124399
GTTS-WK17091MR IVTScrip™ mRNA-Human AP4B1-AS1, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA AP4B1-AS1
GTTS-WK14784MR IVTScrip™ mRNA-Human AL117190.2, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AL117190.2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →